AUTHORS
Pratiksha Patel, Priyanka Patel, James E. Meiring, Theresa Misiri, Felistas Mwakiseghile, and Melita A. Gordon
ABSTRACT
The marathon of vaccinating children began on February 21, 2018, at 10:13 AM, with 4-year-old Golden becoming the first child in Africa to be enrolled in a typhoid conjugate vaccine study.The day of Golden’s vaccination was eventful, and all were uttering the same phrase, “27,999 children to be vaccinated by the end of September 2018,” our finish line. The Typhoid Vaccine Acceleration Consortium (TyVAC) is led by the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, the Oxford Vaccine Group at the University of Oxford, and PATH. The Typhoid Vaccine Acceleration Consortium is funded by the Bill & Melinda Gates Foundation. This study is part of the TyVAC, a partnership between the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, the Oxford, and PATH. This vaccine efficacy study is the biggest of its kind to ever be conducted in Blantyre, Malawi.
Click here to read the article, published in the American Journal of Tropical Medicine and Hygiene.
